• Pharmacogenomics of Chloroquine and Hydroxychloroquine

  2026-08-20

  Biswas and Sukasem synthesize the limited pharmacogenomic evidence for chloroquine and hydroxychloroquine, focusing on CYP2C8, CYP3A4/5, and CYP2D6 variation as potential determinants of exposure, efficacy, and toxicity. Their risk-phenotype framework highlights why ultra-rapid and poor metabolizer states may complicate treatment across populations, while also showing that stronger clinical validation is still needed.

• Proteinase K: Selectivity Lessons for DNA Workflows

  2026-08-20

  Proteinase K is more than a routine digestion reagent: its stability and broad substrate range can be used strategically for DNA sample preparation and assay controls. This article connects molecular biology workflows with a SARS-CoV-2 protease study to explain selectivity, orthogonal validation, and DNA integrity preservation.

• One-step TUNEL Cy3 Apoptosis Detection Kit

  2026-08-19

  The One-step TUNEL Cy3 Apoptosis Detection Kit provides a practical DNA-fragmentation endpoint for studying hepatic ischemia-reperfusion injury. This article explains how to interpret TUNEL results alongside JNK-centered mechanistic evidence, with assay decisions for tissue sections and cultured cells.

• Oteseconazole (VT-1161) Research Workflows

  2026-08-19

  Build reproducible Candida susceptibility assays around Oteseconazole (VT-1161), a selective tetrazole CYP51 inhibitor with activity against fluconazole-resistant strains. This guide connects concentration planning, transporter-aware interpretation, controls, and troubleshooting for antifungal discovery workflows.

• Actinomycin D Workflows for RNA Stability and Stress

  2026-08-18

  Actinomycin D provides a practical transcription-shutdown step for measuring mRNA decay, transcriptional stress, and apoptosis in cell models. This workflow connects SQSTM1 RNA stability research in diabetic keratinocytes with broader cancer research applications while emphasizing controls, solubility, and interpretation limits.

• Pazopanib: ATRX-Aware Cancer Research

  2026-08-18

  Pazopanib (GW-786034) is a multi-targeted kinase inhibitor with applications extending beyond angiogenesis studies. This guide develops an ATRX-aware framework for interpreting pazopanib responses in glioma and other cancer research models.

• Praeruptorin A and NF-κB Signaling in Macrophages

  2026-08-17

  The reference study shows that Praeruptorin A suppresses poly(I:C)-induced inflammatory responses in RAW264.7 macrophages by reducing inflammatory gene expression and NF-κB pathway activation. Its integrated RNA-sequencing and molecular validation workflow provides a useful model for studying TLR3-associated inflammation while clarifying the limits of extrapolating cell-culture findings to viral disease or other therapeutic areas.

• Anti-HMGB1 Rabbit Monoclonal Antibody Guide

  2026-08-17

  Anti-HMGB1 Rabbit Monoclonal Antibody MA3057 supports research detection of HMGB1 in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It should be used as a research reagent only, with assay-specific optimization, and not for diagnostic, therapeutic, or medical applications.

• Actinomycin D for PD-L1 RNA Stability Assays

  2026-08-16

  Actinomycin D enables researchers to separate transcriptional output from mRNA decay in pancreatic cancer models. This practical guide connects ActD treatment with glutamine–STAT3–PD-L1 biology, offering assay design, optimization, and troubleshooting strategies for cancer research.

• Chloramphenicol for Plasmid Selection Workflows

  2026-08-15

  Chloramphenicol combines defined ribosomal inhibition with practical, marker-based control of plasmid maintenance and transfer assays. This guide connects product handling and selection optimization with recent evidence on carbapenemase gene mobility, while clearly separating validated findings from workflow recommendations.

• Aurora A Beyond Mitosis: The Alisertib Imperative

  2026-08-14

  MLN8237 (Alisertib) offers a precise way to interrogate Aurora A biology as it extends from mitotic control and tumor cell death into trained immunity, SAM metabolism, and translational oncology strategy.

• OSMI-1 and the Placental O-GlcNAc–Ferroptosis Axis

  2026-08-14

  The O-GlcNAc–HUWE1–TfR1 pathway links nutrient-sensitive protein modification to iron handling, ferroptosis, and trophoblast syncytialization in preeclampsia. This thought-leadership guide positions OSMI-1 as a mechanistic O-GlcNAc transferase inhibitor for testing pathway directionality, target engagement, and translational boundaries—not as a validated treatment for preeclampsia.

• Pemetrexed Workflows for Tumor Cell Research

  2026-08-13

  Build reproducible pemetrexed disodium assays that connect folate-pathway inhibition with tumor-cell response, DNA-repair status, and combination-treatment design. This workflow translates malignant mesothelioma findings into practical dose-response, biomarker, and troubleshooting strategies for cancer chemotherapy research.

• Proteinase K for DNA and EV Workflows

  2026-08-13

  Proteinase K combines broad protein digestion with compatibility across DNA extraction conditions, making it useful for nuclease removal, genomic DNA recovery, and controlled protein-accessibility assays. This article translates its biochemical profile and a recent Candida albicans extracellular-vesicle study into practical workflows, optimization choices, and troubleshooting strategies.

• Merimepodib (VX-497) Research Workflows

  2026-08-12

  Merimepodib (VX-497) enables mechanism-focused studies of IMPDH-dependent guanine nucleotide biosynthesis across antiviral, immunology, and cancer models. This practical guide connects concentration planning, guanosine-rescue experiments, infection workflows, and troubleshooting to recent evidence from PEDV research.

16174 records 1/1079 page Next 12345 下5页 Last page